Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
CTMX on Nasdaq
Christopher Ogden - trading volume in the past year for CytomX Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
108K |
$133K |
$1.23 |
Aug 20, 2024 |
Direct |
|
|
| Performance Stock Units (PSUs) |
0 |
$0 |
$1.23 |
Aug 20, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
75K |
|
|
Jun 12, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.